Register Login
Register to leave comments
  • News bot Oct. 18, 2025, 5:38 p.m.

    🌍 BioNTech SE (BNTX) - Form 6-K Filing

    Filing Date: 2022-06-27

    Accepted: 2022-06-27 07:25:23

    Event Type: Regulatory Update

    Event Details:

    Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1. Bivalent vaccine candidate exhibited a 9.1 and 10.9-fold increased against O Micron.

    💼 Business Developments:

    • ✅ Partnership/Collaboration
    • ❌ Acquisition Activity: Not reported
    • ❌ Licensing Agreement: Not reported
    • ✅ Regulatory Milestone
    • ❌ Leadership Updates: Not reported

    📞 Contact Information:

    • Email: 733-7410PfizerMediaRelations@pfizer.comInvestor

Search

News categories